Showing results (31-40 of 451) with videos related to

Sort By:
Pageof 46
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 19, 2024
Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation modelRunguo Wu, Claire Williams, Junwen Zhou, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 12, 2014
Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP)Richard Haynes, Natalie Staplin, Jonathan Emberson, et al.
BMC Nephrology|May 1, 2015
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?Seamus Kent, Iryna Schlackow, Jingky Lozano-Kühne, et al.
Pharmacoeconomics|February 24, 2023
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UKJunwen Zhou, Runguo Wu, Claire Williams, et al.
Eclinicalmedicine|July 21, 2025
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trialJunwen Zhou, Claire Williams, Natalie Staplin, et al.
Lancet (London, England)|July 18, 2020
COVID-19 pandemic and admission rates for and management of acute coronary syndromes in EnglandMarion M Mafham, Enti Spata, Raphael Goldacre, et al.
Health Technology Assessment (Winchester, England)|December 7, 2024
Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data setsBorislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
The Lancet Regional Health. Europe|March 29, 2024
Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling studyBorislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
Heart (British Cardiac Society)|September 10, 2024
Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling studyBorislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
Lancet (London, England)|June 2, 2009
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Colin Baigent, Lisa Blackwell, et al.
Pageof 46